Alphatec Holdings (Alphatec Holdings) Cash And Cash Equivalents : $221.0 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Alphatec Holdings Cash And Cash Equivalents?

Alphatec Holdings's quarterly cash and cash equivalents increased from Jun. 2023 ($101.02 Mil) to Sep. 2023 ($122.53 Mil) and increased from Sep. 2023 ($122.53 Mil) to Dec. 2023 ($220.97 Mil).

Alphatec Holdings's annual cash and cash equivalents declined from Dec. 2021 ($187.25 Mil) to Dec. 2022 ($84.70 Mil) but then increased from Dec. 2022 ($84.70 Mil) to Dec. 2023 ($220.97 Mil).

Alphatec Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Alphatec Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphatec Holdings Cash And Cash Equivalents Chart

Alphatec Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

47.11

107.77

187.25

84.70

220.97

Alphatec Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															84.70	116.70	101.02	122.53	220.97

Alphatec Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Alphatec Holdings (NAS:ATEC) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Alphatec Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Alphatec Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphatec Holdings (Alphatec Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alphatec Holdings Inc (NAS:ATEC) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

L1Z1:Germany

Address

1950 Camino Vida Roble, Carlsbad, CA, USA, 92008

Website

https://www.atecspine.com

Alphatec Holdings Inc is a medical technology company focused on the design, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Executives

David Sponsel	officer: EVP, Sales	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
David M Demski	director	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Patrick Miles	director, officer: Executive Chairman	7475 LUSK BLVD., SAN DIEGO CA 92121
Tullis James L L	director, 10 percent owner	100 FIRST STAMFORD PLACE, STAMFORD CT 06907
David H Mowry	director	9775 TOLEDO, IRVINE CA 92618
Evan Bakst	director	225 CENTRAL PARK WEST, APT. 1605, NEW YORK NY 10024
Jennifer N. Pritzker	10 percent owner	C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Tyson Eliot Marshall	officer: GENERAL COUNSEL & CORP. SEC.	10680 TREENA STREET, SUITE 500, SAN DIEGO CA 92131
Craig E Hunsaker	officer: See Remarks	C/O ALPHATEC HOLDINGS, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Paul Segal	10 percent owner	1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
L-5 Healthcare Partners, Llc	10 percent owner, other: Director by deputization	1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
John Todd Koning	officer: Chief Financial Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
David R Pelizzon	director, 10 percent owner	2850 FRONTIER DR, WARSAW IN 46582
Scott Lish	officer: SVP, Development	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008